Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Lethal effect of the anti-Fas antibody in mice

An Erratum to this article was published on 07 October 1993

Abstract

DURING mammalian development, many cells are programmed to die1,2 most mediated by apoptosis3. The Fas antigen4 coded by the structural gene for mouse lymphoproliferation mutation (lpr)5,6, is a cell surface protein belonging to the tumour necrosis factor/nerve growth factor receptor family7,8, and mediates apoptosis7. The Fas antigen messenger RNA is expressed in the thymus, liver, heart, lung and ovary8. We prepared a monoclonal antibody against mouse Fas antigen, which immunoprecipitated the antigen (Mr 45K) and had cytolytic activity against cell lines expressing mouse Fas antigen. We report here that staining of mouse thymocytes with the antibody indicated that thymocytes from the wild-type and lprcg mice expressed the Fas antigen, whereas little expression of the Fas antigen was found in lpr mice. Intraperitoneal administration of the anti-Fas antibody into mice rapidly killed the wild-type mice but neither lpr nor lprcg mice. Biochemical, histological and electron microscope analyses indicated severe damage of the liver by apoptosis. These findings suggest that the Fas antigen is important in programmed cell death in the liver, and may be involved in fulminant hepatitis in some cases.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Raff, M. C. Nature 356, 397–400 (1992).

    ADS  CAS  Article  Google Scholar 

  2. 2

    Ellis, R. E., Yuan J. & Horvitz, H. R. A. Rev. Cell Biol. 7, 663–698 (1991).

    CAS  Article  Google Scholar 

  3. 3

    Wyllie, A. H., Kerr, J. F. R. & Currie, A. R. Int. Rev. Cytol. 68, 251–306 (1980).

    CAS  Article  Google Scholar 

  4. 4

    Yonehara, S., Ishii, A. & Yonehara, M. J. exp. Med. 169, 1747–1756 (1989).

    CAS  Article  Google Scholar 

  5. 5

    Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A. & Nagata, S. Nature 356, 314–317 (1992).

    ADS  CAS  Article  Google Scholar 

  6. 6

    Adachi, M., Watanabe-Fukunaga, R. & Nagata, S. Proc. natn. Acad. Sci. U.S.A. 90, 1756–1760 (1993).

    ADS  CAS  Article  Google Scholar 

  7. 7

    Itoh, N. et al. Cell 66, 233–243 (1991).

    CAS  Article  Google Scholar 

  8. 8

    Watanabe-Fukunaga, R. et al. J. Immun. 148, 1274–1279 (1992).

    CAS  PubMed  Google Scholar 

  9. 9

    Meier, T., Arni, S., Malarkannan, S., Poincelet, M. & Hoessli, D. Analyt. Blochem. 204, 220–226 (1992).

    CAS  Article  Google Scholar 

  10. 10

    Kimura, M. et al. Immunology 76, 498–504 (1992).

    CAS  PubMed  PubMed Central  Google Scholar 

  11. 11

    Trauth, B. C. et al. Science 245, 301–305 (1989).

    ADS  CAS  Article  Google Scholar 

  12. 12

    Oehm, A. et al. J. biol. Chem. 267, 10709–10715 (1992).

    CAS  PubMed  Google Scholar 

  13. 13

    Lehmann, V., Freudenberg, M. A. & Galanos, C. J. exp. Med. 165, 657–663 (1993).

    Article  Google Scholar 

  14. 14

    Eskandari, M. K. et al. J. Immun. 148, 2724–2730 (1992).

    CAS  PubMed  Google Scholar 

  15. 15

    Watson, J., Kelly, K., Largen, M. & Taylor, B. A. J. Immun. 120, 422–424 (1978).

    CAS  PubMed  Google Scholar 

  16. 16

    Waage, A. & Espevik, T. J. exp. Med. 167, 1987–1992 (1988).

    CAS  Article  Google Scholar 

  17. 17

    Tracey, K. J. et al. Science 234, 470–474 (1986).

    ADS  CAS  Article  Google Scholar 

  18. 18

    Benedetti, A., Jezaquel, A. M. & Orlandi, F. J. Hepat. 7, 319–324 (1988).

    CAS  Article  Google Scholar 

  19. 19

    Potten, C. S. Cancer Metastasis Rev. 11, 95–103 (1992).

    Article  Google Scholar 

  20. 20

    Chisari, F. V. Molec. Gen. Med. 2, 67–103 (1992).

    CAS  Article  Google Scholar 

  21. 21

    Rouvier, E., Luciani, M.-F. & Golstein, P. J. exp. Med. 177, 195–200 (1993).

    CAS  Article  Google Scholar 

  22. 22

    Falk, M. H. Blood 79, 3300–3306 (1992).

    CAS  PubMed  Google Scholar 

  23. 23

    Debatin, K.-M., Goldmann, C. K., Bamford, R., Waldman, T. A. & Krammer, P. H. Lancet 335, 497–500 (1990).

    CAS  Article  Google Scholar 

  24. 24

    Kobayashi, N. et al. Proc. natn. Acad. Sci. U.S.A. 87, 9620–9624 (1990).

    ADS  CAS  Article  Google Scholar 

  25. 25

    Sanchez-Madrid, F., Szklut, P. & Springer, T. A. J. Immun. 130, 309–312 (1983).

    CAS  PubMed  Google Scholar 

  26. 26

    Hirata, Y. et al. J. Immun. 143, 2900–2906 (1989).

    CAS  PubMed  Google Scholar 

  27. 27

    Cligan, J. E., Kruisbeek, A. M., Hargulies, D. H., Shevach, E. M. & Strober, W. Current Protocols in Immunology (Wiley Interscience, New York, 1991).

    Google Scholar 

Download references

Author information

Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Ogasawara, J., Watanabe-Fukunaga, R., Adachi, M. et al. Lethal effect of the anti-Fas antibody in mice. Nature 364, 806–809 (1993). https://doi.org/10.1038/364806a0

Download citation

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links